Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
10.50
-0.76 (-6.75%)
At close: Oct 2, 2026, 4:00 PM EDT
10.50
0.00 (0.00%)
After-hours: Oct 2, 2026, 4:16 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $27 | Buy | Maintains | $27 | +157.14% | Oct 2, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $28 | Buy | Maintains | $28 | +166.67% | Oct 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +252.38% | Oct 2, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $25 | Buy | Initiates | $25 | +138.10% | Oct 1, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $27 | Buy | Maintains | $27 | +157.14% | Aug 11, 2026 |
| Jefferies | Jefferies | Buy Maintains $25 | Buy | Maintains | $25 | +138.10% | Jul 31, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $29 | Buy | Reiterates | $29 | +176.19% | Jun 24, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.